Congenital Cardiac Anesthesia Society
A Section of the the Society for Pediatric Anesthesia

Congenital Cardiac Anesthesia Society

  • Member Login
  • Forgot Password?
  • Join
  • Home
  • About
    • Mission Statement
    • Bylaws
    • Board of Directors
    • History
    • Past Presidents
    • Charter Members
    • CCAS Lifetime Achievement Award
    • Mailing List Rental
    • Contact Us
  • Partners
    • SPA
    • SPPM
    • PALC
    • PCICS
    • AmSECT
    • SMACT
    • CHA
    • CCAN
  • Committees
    • CCAS Committees
      • Pediatric Cardiac Anesthesiology Program Director’s Group (PCAPD) Committee
      • Communications Committee
      • CCAS-STS Database Committee
      • Education Committee
      • Global Health Committee
      • Membership Committee
      • Quality and Safety Committee
      • Research Committee
    • CCAS Special Interest Groups
      • Adult Congenital Heart Disease Special Interest Group (SIG)
      • ERAS Special Interest Group (SIG)
      • Hemostasis Special Interest Group (SIG)
      • Latin America Special Interest Group (SIG)
      • Pulmonary Hypertension Special Interest Group (SIG)
      • Trainee Special Interest Group (SIG)
  • Membership
    • Benefits of Membership
    • CCAS Member App
    • Membership Categories
    • Join CCAS
      • Online Application
      • Printable Application
    • Renew Your Dues
    • Sponsor a Member
    • Get Involved
  • Meetings
    • Upcoming Meetings
    • Past Meetings
    • Other Meetings
    • Exhibit Information
  • Education
    • CCAS Virtual Visiting Professor Program
    • CCAS Webinar Series
      • CCAS Webinar Series – Recordings
    • CCAS COVID 19 Webinar
    • ACHD-SIG Anesthesia Rounds
    • Lecture Series
    • Echo Tutorial
    • Archived Questions
    • Poll of the Month Archives
    • Review Articles
      • CCAS-CHiP Network Journal Watch Collaboration
      • SCVA Articles
    • Journals of Interest
    • Books of Interest
    • Educational Links
  • Resources
    • CCAS Position Statements
    • CCAS Committee Resources
    • CCAS Special Interest Group (SIG) Resources
    • CCAS Cognitive Aids
    • Newsletters
    • Research Resources
    • Mission Trips
    • Societies
    • Job Opportunities
  • Research
    • Research Committee
    • CCAS 2025 Meeting Scholarship for Students and Residents
    • Research Network & Collaborative Opportunities
    • Research Resources
    • Dolly D. Hansen, MD Research Award
    • New for 2026! CCAS QI/Education Award
    • Podcast Series for Aspiring CCAS Researchers
    • Highlight on a CCAS Researcher
    • Call for Surveys
    • STS-CCAS Database
    • Donate to the Dolly Hansen Fund
  • Trainees
    • Introduction to Pediatric Cardiac Anesthesiology
    • Trainee Lecture Series
    • Advanced Training
    • Pediatric Cardiac Anesthesiology Fellowship Common Goals and Objectives
    • Frequently Asked Questions
    • Pediatric Cardiac Anesthesia Education Resources
    • Coaching/Mentoring Initiative
  • Patients
    • FAQs for Cardiac Anesthesia
    • FAQs for Cardiac Anesthesia – Spanish
    • SmartTots FAQs for Parents
    • Useful Resources for Parents

Question of the Week 530

Author: Manal Mirreh, MD – Children's Hospital of Philadelphia, Philadelphia, PA


A 2-month-old full-term boy with polysyndactyly/syndactyly/nail hypoplasia of the left foot, aplasia cutis, and cutis marmorata telangiectasia congenita presents to cardiology clinic for routine follow-up of a patent ductus arteriosus (PDA). His initial echocardiogram on day of life two showed bidirectional flow in his PDA, with normal RV pressure. His new echocardiogram now indicates suprasystemic right ventricular pressure, RV dysfunction and possible multivessel pulmonary vein disease. Given the physical exam and echocardiogram findings, which of the following genetic syndromes is the MOST likely present in this patient?

Correct! Wrong!

EXPLANATION


If a patient presents with skin (scalp) and limb defects plus signs of pulmonary hypertension, Adams-Oliver syndrome (AOS) should be considered.


Adams-Oliver Syndrome is a rare genetic disorder characterized by a distinct combination of congenital anomalies. The hallmark features include aplasia cutis congenita, most often presenting as areas of missing skin on the scalp, and transverse limb defects, such as missing digits, hypoplastic nails, or syndactyly. Many patients also exhibit cutaneous and vascular abnormalities, including cutis marmorata telangiectatica congenita (CMTC). CMTC is a rare congenital disorder characterized by discolored patches of skin caused by widened (dilated) surface blood vessels. As a result, the skin has a purple or blue “marbled” or “fishnet” appearance (cutis marmorata). Importantly, cardiovascular involvement is common and may include congenital heart defects as well as pulmonary hypertension, which is thought to arise from underlying vascular dysplasia.1 The syndrome can follow an autosomal dominant or recessive inheritance pattern, with mutations in genes such as ARHGAP31, DOCK6, and NOTCH1 identified in affected individuals.2


Cutis marmorata is a common benign reticulate marbling of the skin described in neonates. It represents a physiologic phenomenon, with exacerbation on exposure to cold and resolution with re-warming. 


It remains somewhat unclear as to whether the prognosis of AOS without lethal anomalies alters the lifespan. However, it is very likely that limited forms of the disease with only skin and skeletal abnormalities are likely to be associated with a better prognosis and no reduction in lifespan as compared to those patients with systemic involvement.3


Holt-Oram syndrome is caused by mutations in the TBX5 gene and follows an autosomal dominant inheritance pattern. It is characterized primarily by abnormalities of the upper limbs, which can range from missing or malformed thumbs to more severe reductions of the long bones, such as phocomelia. These limb anomalies are usually bilateral but often asymmetric. A hallmark of Holt-Oram syndrome is its strong association with cardiac defects, especially atrial and ventricular septal defects, as well as cardiac conduction abnormalities ranging from first-degree heart block to more serious rhythm disturbances. Notably, patients with Holt-Oram syndrome do not exhibit scalp defects or intellectual disability.


Alagille syndrome is an autosomal dominant disorder consisting of bile duct paucity, cholestasis, “triangular” facies, widespread vascular anomalies, and congenital heart disease. The congenital heart disease commonly presents as peripheral pulmonary arterial stenosis or hypoplasia or pulmonary valve stenosis.


REFERENCES


1. Zapata, H.H., Sletten, L.J. and Pierpont, M.E.M. (1995), Congenital cardiac malformations in Adams-Oliver syndrome. Clinical Genetics, 47: 80-84. https://doi.org/10.1111/j.1399-0004.1995.tb03928.x


2. MedlinePlus Genetics. Adams-Oliver Syndrome. National Library of Medicine. Updated February 28, 2024. Accessed May 10, 2025. https://medlineplus.gov/genetics/condition/adams-oliver-syndrome/


3. Seo JK, Kang JH, Lee D, Sung HS, Hwang SW. A case of Adams-Oliver syndrome. Ann Derm 2010; 22:96-8.

Poll of the Month

June 2025
At your institution, do patients presenting for elective cardiac surgery who are found to be anemic on routine testing undergo formal preoperative anemia testing and treatment?
View Results
Total Answers 66
Total Votes 66

Upcoming Meeting Information


CCAS 2026 Annual Meeting

March 12, 2026
Sheraton Denver Downtown
Denver, CO

 

 

 

 

Join CCAS
Renew
Donate
Get Involved
Upcoming
Job Postings
  • Member Login
  • Forgot Password?
2209 Dickens Road, Richmond, VA 23230 • 804-282-9780 • [email protected]
Copyright © 2025 The Congenital Cardiac Anesthesia Society | View Privacy Policy